ATAI Life Sciences NV (9VC) — Working Capital to Net Assets Ratio
ATAI Life Sciences NV (9VC) has a Working Capital to Net Assets ratio of 71.4% as of September 2025. Working capital of €114.12 Million (current assets of €130.67 Million minus current liabilities of €16.54 Million) is measured against net assets of €159.91 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 9VC financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ATAI Life Sciences NV Working Capital to Net Assets (2019–2024)
This chart shows how ATAI Life Sciences NV's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 71.4%, reflecting working capital of €114.12 Million against net assets of €159.91 Million EUR. See 9VC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for ATAI Life Sciences NV (2019–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for ATAI Life Sciences NV from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see ATAI Life Sciences NV market cap and net worth.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 47.3% | €55.17 Million | €116.55 Million | €80.12 Million | €24.95 Million | ▼ -20.4 pp |
| 2023 | 67.7% | €165.47 Million | €244.32 Million | €185.59 Million | €20.12 Million | ▼ -32.8 pp |
| 2022 | 100.6% | €267.25 Million | €265.77 Million | €287.14 Million | €19.90 Million | ▲ +8.8 pp |
| 2021 | 91.8% | €354.15 Million | €385.96 Million | €375.08 Million | €20.93 Million | ▲ +0.3 pp |
| 2020 | 91.5% | €87.25 Million | €95.37 Million | €99.55 Million | €12.30 Million | ▲ +28.5 pp |
| 2019 | 62.9% | €37.54 Million | €59.64 Million | €39.15 Million | €1.61 Million | — |